Logo
x

Search

Subscribe Now

ars pharmaceuticals

ARS Pharmaceuticals’ neffy 1mg Secures the US FDA’s Approval to Treat Type I Allergic Reactions in Children

ARS Pharmaceuticals’ neffy 1mg Secures the US FDA’s Approval to Treat Type I Allergic Reactions in Children

  • March 6, 2025
ARS Pharmaceuticals Reports the EC’s Approval of Eurneffy (Adrenaline Nasal Spray) to Treat Type I Allergic Reactions

ARS Pharmaceuticals Reports the EC’s Approval of Eurneffy (Adrenaline Nasal Spray) to Treat Type I Allergic Reactions

  • August 26, 2024
ARS Pharmaceuticals’ neffy (Epinephrine Nasal Spray) Gains the US FDA’s Approval to Treat Type I Allergic Reactions

ARS Pharmaceuticals’ neffy (Epinephrine Nasal Spray) Gains the US FDA’s Approval to Treat Type I Allergic Reactions

  • August 12, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.